OBJECTIVE: We assessed the hypothesis that mental health conditions (MHCs) are associated with higher risk of bleeding in patients with atrial fibrillation (AF). METHODS: The registry-based FinACAF study covers all patients with AF diagnosed during 2007-2018 in Finland. MHCs of interest were depression, bipolar disorder, anxiety disorder, schizophrenia, and any MHC. The outcomes were first-ever gastrointestinal, intracranial, and any bleeding event. RESULTS: We identified 205,019 patients (50.9% female; mean age 72.3 [standard deviation 13.4] years) with incident AF without prior bleeding, and the prevalence of any MHC was 6.1%. Any MHC, depression, and anxiety disorder were associated with the risk of any bleeding (adjusted hazard ratios (...
Publisher Copyright: © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No co...
Objective: Medication adherence is essential for effective stroke prevention in patients with atrial...
Funding Information: Jukka Putaala: Dr. Putaala reports personal fees from Boehringer Ingelheim, per...
OBJECTIVE: We assessed the hypothesis that mental health conditions (MHCs) are associated with highe...
OBJECTIVEWe assessed the hypothesis that mental health conditions (MHCs) are associated with higher ...
Background: Atrial fibrillation (AF) patients with mental health conditions (MHCs) have higher incid...
BackgroundAtrial fibrillation (AF) patients with mental health conditions (MHCs) have higher inciden...
AimsLittle is known about the effects of mental health conditions (MHCs) on the utilization of oral ...
BACKGROUND: Mental health conditions (MHCs) are associated with poor outcomes in patients with atria...
One third of patients with atrial fibrillation (AF) are estimated to suffer from mental health condi...
OBJECTIVES: Mental health conditions (MHCs) have been associated with undertreatment of unrelated me...
BACKGROUND: Mental health conditions (MHCs) are associated with poor outcomes in patients with atria...
OBJECTIVESMental health conditions (MHCs) have been associated with undertreatment of unrelated medi...
Aims Little is known about the effects of mental health conditions (MHCs) on the utilization of oral...
Objective: Medication adherence is essential for effective stroke prevention in patients with atrial...
Publisher Copyright: © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No co...
Objective: Medication adherence is essential for effective stroke prevention in patients with atrial...
Funding Information: Jukka Putaala: Dr. Putaala reports personal fees from Boehringer Ingelheim, per...
OBJECTIVE: We assessed the hypothesis that mental health conditions (MHCs) are associated with highe...
OBJECTIVEWe assessed the hypothesis that mental health conditions (MHCs) are associated with higher ...
Background: Atrial fibrillation (AF) patients with mental health conditions (MHCs) have higher incid...
BackgroundAtrial fibrillation (AF) patients with mental health conditions (MHCs) have higher inciden...
AimsLittle is known about the effects of mental health conditions (MHCs) on the utilization of oral ...
BACKGROUND: Mental health conditions (MHCs) are associated with poor outcomes in patients with atria...
One third of patients with atrial fibrillation (AF) are estimated to suffer from mental health condi...
OBJECTIVES: Mental health conditions (MHCs) have been associated with undertreatment of unrelated me...
BACKGROUND: Mental health conditions (MHCs) are associated with poor outcomes in patients with atria...
OBJECTIVESMental health conditions (MHCs) have been associated with undertreatment of unrelated medi...
Aims Little is known about the effects of mental health conditions (MHCs) on the utilization of oral...
Objective: Medication adherence is essential for effective stroke prevention in patients with atrial...
Publisher Copyright: © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No co...
Objective: Medication adherence is essential for effective stroke prevention in patients with atrial...
Funding Information: Jukka Putaala: Dr. Putaala reports personal fees from Boehringer Ingelheim, per...